Congrats to Study Chair @DrBenTran & the team for recruiting their 200th patient (by Site PI David Campbell @BarwonHealth) on the @ANZUPtrials #TesticularCancer translational study #CLIMATE - reaching FULL recruitment! Well done to all! @WEHI_research @ciaraconduit @Prof_IanD

@DrBenTran late breaking presentation of TYRA-300, a selective FGFR3 inhibitors in patients with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301) at @EORTC @theNCI @AACR #ENASymp24

Three big things in testis cancer! Great GU Cast with testis cancer gurus @RHamiltonUrol @DrBenTran while up at #ANZUP24 ASM recently. Timely overview of some important areas of progress in testis cancer @RenuEapen @declangmurphy

Evon Jude presenting Real World Evidence from Australian RCC registry #KRAB at #ANZUP24 @WEHI_research @WeickhardtOnc

Arsha Anton presenting registry based trial REAL-Pro at #ANZUP24 @WEHI_research

Just published with the #AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell #Carcinoma, by @montypal et al. https://t.co/jnEGEPCegV @cityofhope @AACR

Congrats to Study Chair @DrBenTran & the team for recruiting their 100th patient (by site PI Dr Jeremy Lewin @PeterMacCC) on the @ANZUPtrials #TesticularCancer translational study #CLIMATE. Now has reached 50% recruitment! @WEHI_research @ciaraconduit @CancerAustralia @Prof_IanD

▶️ Go-to journal for #RWD and #digitalhealth research in oncology! https://t.co/pSUvDOWART @flatironhealth @GroupeUnicancer @BCPlatforms @TriNetX @OwkinScience @PromptlyHealth @IQVIA_global @GetReal_Inst @aetioninc @ProstatePioneer @HarmonynetEU @BD4BO @RWE4Decisions @idea4rc

You may not hear of testicular cancer as much as others, but did you know males aged 20-39 are the most commonly diagnosed? Download our Understanding Testicular Cancer booklet 👉 https://t.co/t67RmUSljI With thanks to @DrBenTran, @NarimanAhmadi and @COBLH

SIGN UP: https://t.co/Az6BPmKmRx Our upcoming webinar hosted by @docpook features the best in GU oncology! Join our experts as they analyse the key insights from #ASCO23 & discuss implications for Australian practice. Panel: @DrBenTran @ChunLGan & Dr Tania Moujaber

Congratulations @AndrishaI on winning the best of the best oral presentation at @ANZUPtrials #anzup23 for BLADDA real world evidence! @gu_onc @gibbs_lab @PeterMacCC @WEHI_research

@MonashHealth

Liz Liow presenting KRAB data (Australian real world kidney cancer data) @ANZUPtrials #ANZUP23 at best of the best oral abstract session @WEHI_research @DrDanielHeng

@ResearchWyatt describes the breadth of heterogeneity in local prostate cancer. It's almost impossible to predict which genotype belongs to the dominant clone. Should we combine samples?🤔 #ANZUP23 @ANZUPtrials @RenuEapen @DrBenTran @Prof_IanD

@apolo_andrea giving an outstanding overview of biomarkers of muscle invasive and localized urothelial carcinoma #ANZUP23 @DrBenTran @SimaPorten @Prof_IanD; @WeickhardtOnc; @ANZUPtrials

@DrDarrenFeldman gives a masterclass on “Challenges & Pitfalls in #GCT #TesticularCancer ANZUPtrials @DrBenTran @SimaPorten @Prof_IanD #ANZUP23 @achoud72 @RenuEapen @WeickhardtOnc

So pleased to see our paper evaluating patterns of Relapse in Patients With Stage 1 #TesticularCancer: Utility of @ANZUPtrials Surveillance Recommendations in print @JCOOP_ASCO over the weekend - https://t.co/hChEinur38 @DrBenTran

On behalf of @WEHI_research & @TRUECOM1 we’re pleased to share the results of the #REVAMP trial comparing ferric carboxymaltose (#FCM) with oral #iron to treat antenatal #anaemia in pregnant Malawian Women just out in @TheLancet. https://t.co/LUU3M41G5F

Front line role of our leading cancer researchers at #AACR23 in tackling one of cancers holy grails - targeting the RAS oncogene @bensolomon1 #JayeshDesai https://t.co/GgTUCXTK3p

#ESMO Advanced Course on Early Drug Development, 24-25 Feb 2023 in Singapore. Registration deadline: 27 Nov. 🔗 https://t.co/Zf0xvPLf4k #DrugDevelopment @ElenaGarralda @plummer_ruth @lillian_siu @danieltanmd @DrBenTran